ATE212846T1 - Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund - Google Patents

Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund

Info

Publication number: ATE212846T1
Authority: AT; Austria
Prior art keywords: bisphosphonate; bone loss; inhibiting bone; compositions containing; resorption agents
Prior art date: 1994-07-22

Application number

AT95305083T

Other languages

English (en)

Inventor

Larry John Black

George Joseph Cullinan

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-22

Filing date

1995-07-20

Publication date

2002-02-15

1995-07-20 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2002-02-15 Application granted granted Critical

2002-02-15 Publication of ATE212846T1 publication Critical patent/ATE212846T1/de

Links

229940122361 Bisphosphonate Drugs 0.000 title abstract 2
206010065687 Bone loss Diseases 0.000 title abstract 2
150000004663 bisphosphonates Chemical class 0.000 title abstract 2
230000002401 inhibitory effect Effects 0.000 title abstract 2
230000000123 anti-resoprtive effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
150000001907 coumarones Chemical class 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Control Of Motors That Do Not Use Commutators (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT95305083T 1994-07-22 1995-07-20 Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund ATE212846T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27936394A	1994-07-22	1994-07-22

Publications (1)

Publication Number	Publication Date
ATE212846T1 true ATE212846T1 (de)	2002-02-15

Family

ID=23068631

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95305083T ATE212846T1 (de)	1994-07-22	1995-07-20	Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund

Country Status (23)

Country	Link
US (1)	US20010051636A1 (de)
EP (1)	EP0693285B1 (de)
JP (1)	JPH0840911A (de)
KR (1)	KR960003726A (de)
CN (1)	CN1079671C (de)
AT (1)	ATE212846T1 (de)
AU (1)	AU693235B2 (de)
BR (1)	BR9503406A (de)
CA (1)	CA2154414A1 (de)
CZ (1)	CZ189195A3 (de)
DE (1)	DE69525291T2 (de)
DK (1)	DK0693285T3 (de)
ES (1)	ES2168336T3 (de)
HU (1)	HUT72754A (de)
IL (1)	IL114683A (de)
NO (1)	NO308194B1 (de)
NZ (1)	NZ272608A (de)
PL (1)	PL181304B1 (de)
PT (1)	PT693285E (de)
RU (1)	RU2149631C1 (de)
TW (1)	TW398975B (de)
UA (1)	UA41909C2 (de)
ZA (1)	ZA956029B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996016646A1 (en) *	1994-11-29	1996-06-06	Hoechst Marion Roussel, Inc.	Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
AU712711B2 (en) *	1994-11-29	1999-11-11	Hoechst Marion Roussel, Inc.	Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
EP0722727A1 (de) *	1995-01-20	1996-07-24	Eli Lilly And Company	Benzofuran-Derivate zur Hemmung der uterinem Fibrose
US5554600A (en) *	1995-01-20	1996-09-10	Eli Lilly And Company	Methods for inhibiting endometriosis
US5512583A (en) *	1995-01-30	1996-04-30	Eli Lilly And Company	Methods of decreasing serum calcium levels
US6479517B1 (en) *	1995-02-28	2002-11-12	Eli Lilly And Company	Phosphorous-containing benzothiophenes
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy
US5958969A (en) *	1996-10-10	1999-09-28	Eli Lilly And Company	Benzo b!thiophene compounds, intermediates, formulations, and methods
GB2324726A (en) *	1997-05-01	1998-11-04	Merck & Co Inc	Combination Therapy for the Treatment of Osteoporosis
US6465445B1 (en)	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en)	1998-06-11	2006-02-28	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2001272916A1 (en) *	2000-07-19	2002-02-05	Eli Lilly And Company	Method for enhancing bone mineral density gain by administration of raloxifene
DE60111574T2 (de)	2001-01-23	2006-05-11	Gador S.A.	Bisphosphonate enthaltende Zusammensetzungen zur Vorbeugung und/oder Heilung von metabolischen Knochenkrankheiten, Verfahren zu ihrer Herstellung und Benutzung dieser Zusammensetzungen
NZ527157A (en) *	2001-03-01	2005-04-29	Emisphere Tech Inc	Compositions for delivering bisphosphonates
RU2192639C1 (ru) *	2001-04-05	2002-11-10	Дальневосточный государственный медицинский университет	Способ прогнозирования нарушений в постменопаузальном периоде
KR20140021045A (ko) *	2002-05-10	2014-02-19	에프. 호프만-라 로슈 아게	골다공증 치료 및 예방용 비스포스폰산
TR200300510A2 (tr) *	2003-04-18	2004-11-22	Sanovel �La� Sanay� Ve T�Caret A.�.	Dağılan alendronat mikropartikül formülasyonu
ES2401769T5 (es) *	2003-09-12	2020-07-01	Amgen Inc	Formulación de disolución rápida de cinacalcet HCl
KR100557086B1 (ko) *	2003-11-14	2006-03-03	한미약품 주식회사	랄록시펜과 비스포스포네이트의 상호 염
WO2005079811A1 (en) *	2004-02-19	2005-09-01	Teva Pharmaceutical Industries Ltd.	Improved therapy using a combination of raloxifene and alendronate
FR2875807B1 (fr)	2004-09-30	2006-11-17	Servier Lab	Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN1304401C (zh) *	2004-12-28	2007-03-14	浙江工业大学	一种阿伦膦酸的制备方法
CN108421044A (zh)	2005-02-03	2018-08-21	综合医院公司	治疗吉非替尼耐药性癌症的方法
GB0506708D0 (en) *	2005-04-01	2005-05-11	Queen Mary & Westfield College	Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
BRPI0618042A2 (pt)	2005-11-04	2011-08-16	Wyeth Corp	usos de uma rapamicina e de uma herceptina, produto, pacote farmacêutico, e, composição farmacêutica
US8022216B2 (en)	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
CN102641270A (zh)	2008-06-17	2012-08-22	惠氏有限责任公司	含有hki-272和长春瑞滨的抗肿瘤组合
US8669273B2 (en)	2008-08-04	2014-03-11	Wyeth Llc	Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
IL264349B2 (en)	2009-04-06	2024-01-01	Wyeth Llc	Regimen comprising neratinib for the treatment of cancer
HUE033581T2 (hu)	2010-06-10	2017-12-28	Seragon Pharmaceuticals Inc	Ösztrogén receptor modulátorok és alkalmazásaik
SG11201403002RA (en)	2011-12-14	2014-07-30	Seragon Pharmaceuticals Inc	Fluorinated estrogen receptor modulators and uses thereof
US20210392934A1 (en) *	2016-03-10	2021-12-23	Enzymotec Ltd.	Lipid compositions and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2914563A (en)	1957-08-06	1959-11-24	Wm S Merrell Co	Therapeutic composition
US3274213A (en)	1961-09-05	1966-09-20	Upjohn Co	Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
BE637389A (de)	1962-09-13
US4230862A (en)	1975-10-28	1980-10-28	Eli Lilly And Company	Antifertility compounds
US4133814A (en)	1975-10-28	1979-01-09	Eli Lilly And Company	2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4400543A (en)	1975-10-28	1983-08-23	Eli Lilly And Company	3-Phenyl-4-benzoyl-1,2-dihydronaphthalenes
US4323707A (en)	1975-10-28	1982-04-06	Eli Lilly And Company	Antifertility compounds
DE3046719C2 (de)	1980-12-11	1983-02-17	Klinge Pharma GmbH, 8000 München	1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
US4418068A (en)	1981-04-03	1983-11-29	Eli Lilly And Company	Antiestrogenic and antiandrugenic benzothiophenes
US5139786A (en) *	1989-07-07	1992-08-18	Ciba-Geigy Corporation	Topical formulations
EP0416689B1 (de)	1989-09-06	1995-11-29	Merck & Co. Inc.	Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren
EP0470310B1 (de)	1990-08-09	1995-11-29	Council of Scientific and Industrial Research	Benzopyrane und Verfahren zu deren Herstellung
JPH04312526A (ja)	1991-04-09	1992-11-04	Fujisawa Pharmaceut Co Ltd	骨疾患治療剤
JP3157882B2 (ja) *	1991-11-15	2001-04-16	帝国臓器製薬株式会社	新規なベンゾチオフエン誘導体
TW366342B (en) *	1992-07-28	1999-08-11	Lilly Co Eli	The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CA2151240A1 (en) *	1992-12-23	1994-07-07	Donna T. Whiteford	Biophosphonate/estrogen therapy for treating and preventing bone loss
US5591753A (en) *	1994-01-28	1997-01-07	Eli Lilly And Company	Combination treatment for osteoporosis

1995
- 1995-07-19 TW TW084107488A patent/TW398975B/zh not_active IP Right Cessation
- 1995-07-19 UA UA95073400A patent/UA41909C2/uk unknown
- 1995-07-19 NZ NZ272608A patent/NZ272608A/xx active IP Right Revival
- 1995-07-19 PL PL95309693A patent/PL181304B1/pl unknown
- 1995-07-19 ZA ZA956029A patent/ZA956029B/xx unknown
- 1995-07-20 HU HU9502193A patent/HUT72754A/hu unknown
- 1995-07-20 NO NO952890A patent/NO308194B1/no not_active IP Right Cessation
- 1995-07-20 KR KR1019950021267A patent/KR960003726A/ko not_active Ceased
- 1995-07-20 DK DK95305083T patent/DK0693285T3/da active
- 1995-07-20 ES ES95305083T patent/ES2168336T3/es not_active Expired - Lifetime
- 1995-07-20 EP EP95305083A patent/EP0693285B1/de not_active Expired - Lifetime
- 1995-07-20 IL IL11468395A patent/IL114683A/en not_active IP Right Cessation
- 1995-07-20 RU RU95114385A patent/RU2149631C1/ru active
- 1995-07-20 DE DE69525291T patent/DE69525291T2/de not_active Expired - Fee Related
- 1995-07-20 CZ CZ951891A patent/CZ189195A3/cs unknown
- 1995-07-20 PT PT95305083T patent/PT693285E/pt unknown
- 1995-07-20 AU AU27112/95A patent/AU693235B2/en not_active Ceased
- 1995-07-20 AT AT95305083T patent/ATE212846T1/de not_active IP Right Cessation
- 1995-07-21 CA CA002154414A patent/CA2154414A1/en not_active Abandoned
- 1995-07-21 CN CN95108916A patent/CN1079671C/zh not_active Expired - Fee Related
- 1995-07-21 JP JP7185512A patent/JPH0840911A/ja not_active Withdrawn
- 1995-07-21 BR BR9503406A patent/BR9503406A/pt not_active Application Discontinuation
2000
- 2000-03-08 US US09/520,737 patent/US20010051636A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO952890D0 (no)	1995-07-20
HU9502193D0 (en)	1995-09-28
BR9503406A (pt)	1996-02-27
RU2149631C1 (ru)	2000-05-27
AU2711295A (en)	1996-02-01
ZA956029B (en)	1997-01-20
TW398975B (en)	2000-07-21
EP0693285A3 (de)	1998-05-06
IL114683A0 (en)	1995-11-27
HUT72754A (en)	1996-05-28
CA2154414A1 (en)	1996-01-23
CN1079671C (zh)	2002-02-27
PL309693A1 (en)	1996-02-05
EP0693285A2 (de)	1996-01-24
EP0693285B1 (de)	2002-02-06
UA41909C2 (uk)	2001-10-15
AU693235B2 (en)	1998-06-25
PL181304B1 (pl)	2001-07-31
NO952890L (no)	1996-01-23
IL114683A (en)	2001-06-14
PT693285E (pt)	2002-06-28
KR960003726A (ko)	1996-02-23
US20010051636A1 (en)	2001-12-13
DE69525291T2 (de)	2002-09-19
ES2168336T3 (es)	2002-06-16
DE69525291D1 (de)	2002-03-21
DK0693285T3 (da)	2002-05-27
JPH0840911A (ja)	1996-02-13
NO308194B1 (no)	2000-08-14
CZ189195A3 (en)	1996-06-12
CN1119940A (zh)	1996-04-10
NZ272608A (en)	2000-05-26

Legal Events

Date	Code	Title	Description
2002-06-15	UEP	Publication of translation of european patent specification
2004-04-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69525291D1 (de)	2002-03-21	Bisphosphonat und anti-Resorption Agentien, enthaltende Zusammensetzungen zur Hemmung der Knochenschwund
ITRM910696A0 (it)	1991-09-18	Composizioni farmaceutiche per l'applicazione per via nasale.
IL136285A0 (en)	2001-05-20	Pharmaceutical compositions containing an acid-labile active component
ATE262329T1 (de)	2004-04-15	Formulierungen und verfahren zur verminderung der toxizität von anti-neoplastischen mitteln
IS4187A (is)	1995-01-10	Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun
ITFI910071U1 (it)	1992-12-25	Piastra per osso per la porzione distale dell'omero.
FR2663836B1 (fr)	1994-09-23	Implant orthopedique ou dentaire multibloc.
MX9704030A (es)	1998-02-28	1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
PL303937A1 (en)	1995-01-09	Application of an antiestrogen compound and pharmaceutical agent
IL119989A0 (en)	1997-04-15	Pharmaceutical compositions for oral treatment of multiple sclerosis
IL84844A0 (en)	1988-06-30	Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
HUP0100024A3 (en)	2002-12-28	Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
AU3868997A (en)	1998-03-19	Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
IL112999A0 (en)	1995-06-29	Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them
IL111580A (en)	1999-10-28	Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
IL105475A0 (en)	1993-08-18	Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
IL111579A (en)	1999-10-28	Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders
ATE111883T1 (de)	1994-10-15	Neue antiulcus-substanz.
EP0744176A3 (de)	2002-05-15	Arzneimittel zur Hemmung von Knochenschwund
IL109866A (en)	2000-06-01	Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
DE69723639D1 (de)	2003-08-28	Benzothiophenverbindungen, Zubereitungen und Verfahren
ES2164234T3 (es)	2002-02-16	Fusacandinas antifungicas.
NO972450L (no)	1997-05-29	Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
IL103856A0 (en)	1993-04-04	Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
ITPD910046A0 (it)	1991-03-06	Pinza per l'estrazione dentale